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do not know whether it is due to the effects of toxic compounds or
whether it is a genetic association. Whether dietary manipulation
will affect the development of obstructive cardiomyopathy remains
to be seen; if it does, diagnosis would need to be made early in life.
Whatever the aetiology of the cardiomyopathy, the association with
tyrosinaemia suggests that caution should be expressed in
counselling parents about prognosis for this disorder, particularly
with regard to liver transplantation, which may not then be the
curative approach that some have suggested.4
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SEROLOGICAL RESPONSE TO HEPATITIS DELTA 
VIRUS IN HEPATITIS D
SiR,&mdash;We essentially agree with Dr Aragona and colleagues (Feb
28, p 478) about the serological response to delta hepatitis. We also
find that in self-limited coinfections of hepatitis B virus (HBV) and
hepatitis delta virus (HDV), antibody responses, particularly IgM,
are short-lived. The humoral response to self-limited HBV/HDV
coinfections may appear delayed in relation to the onset of illness
because initial symptoms may reflect infection with HBV rather
than HDV. This is most obvious in those cases having a typical
"biphasic" course,l,2 where symptomatic acute hepatitis
(presumably HBV-related) is followed by improvement and
subsequent relapse (with appearance of HDV antibody). We do not
believe that acute HBV/HDV coinfection leads to chronicity;
presumably the suppressive effect of HBV on HDV replication,3 in
addition to the usual severity of the hepatitis, prevents this.
We would caution against undue emphasis on IgM antibody in
the serological interpretation of chronic delta hepatitis. We have
seen patients with advanced HDV-related liver disease without
IgM anti-HDV and, conversely, occasional patients with stable
liver histology despite elevated IgM anti-HDV. In addition, levels
of IgM anti-HDV may fluctuate over time, such fluctuations
sometimes coinciding with sudden elevations of liver enzymes. The
association between progressive disease and IgM antibody may be
broadly true but in our experience is insufficient for individual
advice about prognosis. Most (36/38, 95%) of our patients with
chronic HDV infection who have had a liver biopsy (essentially all
those well enough to tolerate it) have chronic active hepatitis or
cirrhosis, irrespective of IgM antibody status.
In our laboratory IgM and IgG anti-HDV are measured by
solid-phase capture radioimmunoassay. Results are expressed in
arbitrary ratio units (RU), the ratio of the test serum cpm to those of
a negative control: a positive result is greater than 2-1 RU. We find
the strength in RU of IgG antibody useful in distinguishing
between acute and chronic HDV infection (table). Anti-HDV IgG
ANTI-HDV ANTIBODY AT PRESENTATION IN DIFFERENT
CATEGORIES OF DELTA HEPATITIS (154 CASES)
is usually much higher in chronic than acute HDV infection, and
following acute HDV superinfection of an HBV carrier, usually
rises progressively to levels associated with chronic delta hepatitis.
Those rare cases of superinfection that are followed by clearance of
both viruses1 do not produce the strong IgG anti-HDV response
seen in chronic HDV infection. We believe, therefore, that patterns
of IgG anti-HDV following coinfection or superinfection are also of
diagnostic benefit. How long IgG anti-HDV persists after self-
limited delta hepatitis remains to be clarified.
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DOES "CENTRAL" OBESITY PREDICT CORONARY
ARTERY DISEASE?
SIR,-Dr Donahue and colleagues (April 11, p 821) have studied
the relation between subscapular skinfold thickness and coronary
heart disease (CHD) in men of Japanese ancestry in Hawaii. They
describe subscapular fat as "central" fat and claim that it is
independently related to serum cholesterol, serum triglycerides,
hypertension, and so on.
We find that skinfold thickness at any one of the four commonly
measured sites is equally related, quintile by quintile, to serum
cholesterol, triglycerides, and systolic and diastolic blood pressure
(table). Quintile by quintile or decile by decile or as linear
regressions the triceps, subscapular, iliac, and abdominal skinfolds
equal summed skinfolds as predictors of lipid levels, triglycerides,
or blood pressure. The thickness of the triceps skinfold and the
fat-shadow measurement on chest X-rays were both linearly related
to 11 year and 16 year cardiovascular mortality in Scotland.1
Although different fat deposits have been variously categorised
as peripheral/central, upper-body/lower-body, or centrifugal/
centripetal, it is by no means certain that differences in anatomical
location are functionally important. Skinfold-skinfold inter-
correlations are all high, averaging 0 75 in adult males and 0-82 in
women aged 20-49, and the individual correlations with lipids or
blood pressure are not meaningfully different with or without age
adjustment. Thus, we do not agree with Donahue et al that the
subscapular skinfold has unique predictive powers or that partial
correlations allow us to ascertain which skinfold of the four best
reflects the illness-causing aspects of fatness.
We agree that fatter individuals are more likely to experience
cardiovascular accidents such as coronary occlusions or stroke, even
after partitioning for cigarette smoking. We also agree that
measurements of subcutaneous (ie, "outer") fat are superior to
SERUM CHOLESTEROL AND DIASTOLIC BLOOD PRESSURE BY
SKINFOLD QUINTILES IN 1639 MALES AGED 20-49
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Source: Tecumseh, Michigan, Community Health Survey Examination, round 2.
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Changing relative contributions of four different skinfolds to
summed skinfold total in men.
Subscapular skinfold behaves more like "peripheral" skinfold and less like
skinfolds of trunk.
weight-for-height indices in their relationships to other risk factors. 2
However, we do not agree that the subscapular skinfold is uniquely
predictive. Moreover the subscapular skinfold does not necessarily
behave like trunk fat over the entire fatness range. At higher levels of
fatness, the subscapular skinfold decreases in its relative
contribution to the summed skinfold total while the iliac and
abdominal skinfolds become an increasing part of the total (figure).
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ACTIVATED MACROPHAGES AND CANCER
SIR,-Dr Munzarova and Dr Kovarik (April 25, p 952) present
the hypothesis that activated macrophages help both the
establishment of tumours and metastasis by the secretion of
substances that favour cell growth and angiogenesis and by their
ability to fuse with malignant cells. This view contradicts the simple
concept of immune surveillance whereby activation of components
of the immune system is invariably beneficial to the host of a
tumour. In principle, however, the interaction of activated
macrophages with tumour cells can either inhibit or promote
tumour growth, depending on the cytotoxic function of the
macrophage or the capacity of these cells to stimulate cell
proliferation and/or angiogenesis.1,2 Since metastatic spread is
usually responsible for fatal outcome in malignant disease, the
proposed role of macrophages for enhancement of metastasis,
possibly by fusion with transformed cells, might be crucial for
prognosis.
Raised neopterin levels, observed in patients with malignant
tumours, seem to be consistent with this view. In vitro, neopterin is
secreted from macrophages after stimulation by interferon-y.3
Investigations in, for example, patients with graft rejection episodes
or active autoimmune disorders support the concept that neopterin
is a marker for activation of the T lymphocyte/macrophage axis. In
patients with certain malignant diseases, a high frequency of raised
neopterin levels has been found. We and others have investigated
the association between neopterin and prognosis in patients with
carcinomas of the uterine cervix lung,6 prostate and ovary
(unpublished). High neopterin levels indicated a poor prognosis.
As neopterin is produced specifically by macrophages (and not by
tumour cells) upon stimulation with interferon-y the results of these
studies indicate that T cells in cancer patients release interferon-y
and thereby prime macrophages. This suggests that T cells still
recognise the transformed cells. Priming of macrophages, however,
cannot be equated with the killing function of these cells. Rather, the
inability of the immune system to clear the organism from the
tumour indicates that there might be a failure in the subsequent
killing of transformed cells by macrophages and cytotoxic T cells.
Whether macrophages are directly involved in establishing
malignant tumour cannot be concluded from our results. The data,
however, do indicate the presence of macrophages stimulated by
interferon-y in patients with certain cancers and suggest that the
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SIR,-Dr Munzarova and Dr Kovarik’s hypothesis on a role for
macrophage-mediated cell fusion in metastasis may prove as
provocatively useful as it is self-confessedly audacious.
The specific example of malignant melanoma apart, it is
interesting to consider the relevance of macrophage-mediated cell
fusion to foreign body tumorigenesis, such as that produced by
exposure to non-biodegradable materials. In vivo experiments with
mineral fibres1 and tissue culture studies of the effects of asbestos on
Chinese hamster cell lines2 and on pleural tissue explants3 have
revealed many karyotypic and chromosomal abnormalities,
including polyploidy and macronuclei. In vivo4 and in vitro5 studies
have also indicated the importance of fibre morphology and
dimensions, fibres longer than about 7 JlII1 and thinner than about
1 ’5 JlII1 being both more carcinogenic and more cytotoxic to lung
cells in culture. Microcinematographic examination of a mouse-
derived macrophage-like cell line treated with asbestos in culture6
has indicated that cells attached to partly phagocytosed long
asbestos fibres may still be viable and undergo mitosis. Similarly,
morphological and ultrastructural investigations of cultured
primary mouse macrophage cells exposed to asbestos utilising
scanning and transmission electron microscopy’ has revealed that
long asbestos fibres may be associated with several macrophages
juxtaposed along its shaft, a feature indicative of partial endocytosis
("frustrated phagocytosis"). Pleural mesothelial cells in culture also
exhibit phagocytic activity on exposure to asbestos fibres.8
Evidence for in vivo cell fusion in human malignant tumours has
been presented,9 and the finding of giant cells in cultured alveolar
epithelial cell lines exposed to asbestos1O has led to the suggestion
that they are formed by cell fusion. Whilst cell fusion may be
induced by a variety of viral and chemical agents, of special
significance to fibre-related tumorigenesis is the production of fused
hybrid mammalian somatic cells by microneedle surgical
stimulation." Perhaps asbestos fibres have a comparable role in
facilitating the cellular fusion of phagocytic cells (macrophages and
mesothelial cells) with other, possibly neoplastic, cells, hence
contributing to malignant transformation and tumour formation.
Such synergism may provide a cellular mechanism for the
tumour-promoting properties of mineral fibre particles, as
